ATOM-IDG Symposium Series
The goal for this outreach event is to explore collaborative activities via a joint symposium that would promote development of drugs from IDG probes. ATOM (Accelerating Therapeutics for Opportunities in Medicine) is a consortium of National Labs, Biotech/Pharma Companies and UCSF. The objective of ATOM is to transform drug discovery from experiment-driven, sequential, and high-failure to computation-driven, integrated and patient-centric
The goal for this outreach event is to explore collaborative activities via a joint symposium that would promote development of drugs from IDG probes. ATOM (Accelerating Therapeutics for Opportunities in Medicine) is a consortium of National Labs, Biotech/Pharma Companies and UCSF. The objective of ATOM is to transform drug discovery from experiment-driven, sequential, and high-failure to computation-driven, integrated and patient-centric
![Alt](/sites/darkmatter.ucsf.edu/files/2021-02/section-bg-23_0.jpg)